Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.900
+0.110 (3.94%)
Dec 20, 2024, 4:00 PM EST - Market closed
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $370.03 million as of December 20, 2024. Its market cap has decreased by -53.13% in one year.
Market Cap
370.03M
Enterprise Value
235.75M
1-Year Change
-53.13%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $370.03M, a decrease of -77.26%. That is a compound annual growth rate of -49.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 370.03M | -54.72% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZimVie | 374.52M |
| REGENXBIO | 370.84M |
| Personalis | 362.92M |
| Delcath Systems | 360.34M |
| Sana Biotechnology | 358.35M |
| AngioDynamics | 344.98M |
| Design Therapeutics | 343.12M |
| Kamada | 341.81M |